Treatment for hemophilia B focuses on factor IX replacement therapy, prophylactic regimens, on-demand treatment, and emerging gene therapy approaches. Growing awareness of rare diseases, improvements in diagnostic capabilities, and advancements in biologic and long-acting therapies are significantly shaping the global hemophilia B market. https://www.databridgemarketresearch.com/reports/global-hemophilia-b-market